RHO and cancer: Beyond functioning as a tumor suppressor, accumulating evidence have more recently indicated that Cav-1, especially when phosphorylated in Tyr14, behaves as an ambiguous partner in cancer [11]–[15], because of its ability to activate pathways involved in cell migration and invasion, such as the Rho/ROCK and Focal adhesion kinases signaling systems [62].